Advertisement

Topics

Xanthus Communications LLC Company Profile

09:02 EST 18th November 2017 | BioPortfolio

Founded by Patricia Vaccarino in 2003, Xanthus Communications is a boutique PR firm with large firm capabilities that is based in Seattle. Xanthus offers the full range of traditional public relations services as well as technologically sophisticated channels of communication. For more information, please scan http://www.xanthuscom.com. In 2007, Xanthus launched a second website to house its individual clients who are all professionals in their respective fields. Please see http://www.prforpeople.com.


News Articles [171 Associated News Articles listed on BioPortfolio]

Xanthus: Evolving Business Strategies

Fintan Walton talks to Mike Boss, Chief Business Officer, Xanthus Pharmaceuticals, about his role in the evolution of Xanthus, a biopharmaceutical company founded in 2001. After covering Mike's indust...

Antisoma Plc acquires Xanthus Pharmaceuticals

On 11th June 2008, Antisoma Plc finalized their acquisition of Xanthus Pharmaceuticals. In this interview, Fintan Walton talks to Nicholas Adams, Director of Business Development at Antisoma, and Dr M...

Charter Communications To Replace DuPont In S&P 100

MIDLAND (dpa-AFX) - S&P Dow Jones Indices said that S&P 500 constituent Charter Communications Inc. (CHTR) will replace E. I. du Pont de Nemours and Co. (DD) in the S&P 100, and SBA Communications...

Arkadin Introduces New Cisco Spark Services to Extend Global Leadership in Cloud Enterprise Communications

Digital Workspace Spans all Modes of Communication with Global Audio Integration and Trusted Managed Services Arkadin, an NTT Communications company and leader in Cloud Unified Communications and ...

On4 Communications Announces a 73.6% Increase in Revenue Over 2nd Quarter

NEW YORK, NY--(Marketwired - Sep 15, 2017) - On4 Communications, Inc. ( OTC : ONCI) today announced it has released its financials with Read more...

3D Communications Expands Value Communications for Market Access Services with the Addition of Liz Scherer

WASHINGTON, Sept. 20, 2017 /PRNewswire/ -- 3D Communications LLC today announced the expansion of its global Value Communications for Market Access services adding Liz Scherer, a seasoned communi...

On4 Communications to Meet With BMW at Its Corporate Headquarters in Munich, Germany on ...

NEW YORK, NY--(Marketwired - Aug 31, 2017) -  On4 Communications ( OTC : ONCI) today announced it will meet with BMW on September 15, Read more...

Währungsanleihe: Verizon Communications Inc.

Verizon Communications Inc. ist einer der international führenden Telekommunikationsanbieter in den Bereichen Mobilfunk, Internet und Festnetz. Das Unternehmen zählt zu einem der größten US-amerik...

Drugs and Medications [0 Results]

None

PubMed Articles [27 Associated PubMed Articles listed on BioPortfolio]

Type IV Pili-Dependent Motility as a Tool to Determine the Activity of c-di-GMP Modulating Enzymes in Myxococcus xanthus.

The nucleotide-based second messenger bis-(3'-5')-cyclic dimeric GMP (c-di-GMP) regulates multiple processes in bacteria including cellular motility. The rod-shaped Myxococcus xanthus cells move in th...

The type IV pilus assembly ATPase PilB functions as a signaling protein to regulate exopolysaccharide production in Myxococcus xanthus.

Myxococcus xanthus possesses a form of surface motility powered by the retraction of the type IV pilus (T4P). Additionally, exopolysaccharide (EPS), the major constituent of bacterial biofilms, is req...

Catalytic Activity Profile of Polyphosphate Kinase 1 from Myxococcus xanthus.

Polyphosphate kinase 1 (Ppk1) catalyzes reverse transfer of the terminal phosphate from ATP to form polyphosphate (polyP) and from polyP to form ATP, and is responsible for the synthesis of most of ce...

Communications of the median nerve in fetuses.

Communications between the median, ulnar and musculocutaneous nerves in the arm, forearm and hand were reported in adult cadaveric and electrophysiological studies. These communicant branches may lead...

Changes in prescribing and healthcare resource utilization after FDA Drug Safety Communications involving zolpidem-containing medications.

Products containing the sedative/hypnotic zolpidem were subject to Drug Safety Communications (DSCs) in January and May 2013 describing the risk of next-morning impairment and recommending lower start...

Clinical Trials [11 Associated Clinical Trials listed on BioPortfolio]

Multi-level Communications and Access Strategies to Improve the Food Environment

The overarching goal of B'More Healthy Retail Rewards (BHRR) is to develop, implement, and evaluate a pilot multi-level communications and pricing intervention to improve access to and con...

HERrespect Evaluation

This study evaluates whether a factory wide intervention, HERrespect, can reduce female garment workers' experiences of intimate partner violence, and experience and/or witnessing of viole...

Improving the Outpatient Referral Process With Electronic Communications

An electronic referral application will be developed and integrated into the existing outpatient information system. The primary goal of this software is to improve the quality and coordi...

The ACHIEVA Study of Enhanced Pharmacist Care on Antidepressant Use and Response

This a comparative study of enhanced pharmacist care and regular care of patients starting on antidepressants. When providing participants with enhanced care pharmacists will use the Healt...

Electronic Communications and Home Blood Pressure Monitoring

The control of blood pressure (BP) for patients with hypertension on medications has been elusive, despite the availability of evidence-based nationally recognized guidelines for treatment...

Companies [415 Associated Companies listed on BioPortfolio]

Xanthus Communications LLC

Founded by Patricia Vaccarino in 2003, Xanthus Communications is a boutique PR firm with large firm capabilities that is based in Seattle. Xanthus offers the full range of traditional public relations...

Xanthus Pharmaceuticals, Inc

Xanthus is a biopharmaceutical company focused on the discovery, development, acquisition and commercialization of small-molecule therapeutics for the treatment of cancer and autoimmune disorders. We ...

XO Communications

XO Communications provides the technology that helps business and wholesale customers compete in a hyper-connected economy. In the U.S., XO owns and operates one of the largest IP...

GULF TEL COMMUNICATIONS

GulfTel Communications is a proud member of the RLEC Division of Madison River Communications.We are a locally-managed company, close to our customers and driven by their needs and expectations. Yet w...

Legend Communications

Legend Communications is one of the leading Converged Communications Providers in the UK offering combined Internet and Telecommunication solutions to residential, business, corporate and partner audi...

More Information about "Xanthus Communications LLC" on BioPortfolio

We have published hundreds of Xanthus Communications LLC news stories on BioPortfolio along with dozens of Xanthus Communications LLC Clinical Trials and PubMed Articles about Xanthus Communications LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Xanthus Communications LLC Companies in our database. You can also find out about relevant Xanthus Communications LLC Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record